VALIDATED EXECUTIVE ENGAGEMENTS
POOL + OUTREACH
INTERACTIONS
PARTICIPANTS
VALIDATIONS
* Login to view program details and full enterprise executive list.
DATE
JULY 2020
TABLES
18
PAGES
72
EDITION
18
PRICE
USD $5600
Tapping into New Geographical Markets is a Great Way to Grow!
What's Your Addressable Opportunity in the Sepsis Therapeutics Market?
INSIDER ACCESS PRIVILEGES
KEY DIFFERENTIATORS
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Sepsis - A Prelude |
| Recent Market Activity |
| New Treatment Protocols and New Definitions - Every Minute Counts!! |
| Aging Population: A Key Growth Driver for Sepsis Therapeutics |
| Antibiotics and Vasopressors - The Current Standard of Care |
| Current Categories of Antibacterial Agents for First-line Sepsis Treatment |
| Current Anti-bacterial Drugs used in Sepsis |
| Current Antifungals used for Sepsis |
| Current Antivirals used for Sepsis |
| GIAPREZA - The Only FDA Approved Branded Drug for Sepsis Treatment |
| Argipressin Gains Approval for Septic Shock in 26 EU countries |
| Current & Future Analysis |
| Growth Drivers in a Nutshell |
| Market Restraints |
| Global Competitor Market Shares |
| Sepsis Therapeutics Competitor Market Share Scenario Worldwide (in %): 2020 & 2029 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| Adrenomed AG (Germany) |
| AM-Pharma B.V. (Netherlands) |
| AMOMED Pharma GmbH (Austria) |
| Asahi Kasei Pharma America (USA) |
| Endacea, Inc. (USA) |
| InflaRx N.V. (Germany) |
| La Jolla Pharmaceutical Company (USA) |
| TaiRx, Inc. (USA) |
| 3. MARKET TRENDS & DRIVERS |
| A Market Characterized by High Unmet Medical Needs |
| Research Activity Enables Increased Awareness of Disease Pathogenesis |
| Select Sepsis Therapeutics under Phase IV Clinical Trials: As of 2018 |
| Select Sepsis Therapeutics under Phase III Clinical Trials: 2018 |
| Novel Immune-Specific Modes of Action under Focus |
| Emphasizing on Endothelial Cell Function |
| HMGB1 - A Potential Target for Future Therapies |
| Nanoparticle Systems Demonstrate Potential for Use in Septic Shock Management |
| Researchers Employ IL-7 to Increase CD4 and CD8 Immune Cells in Patients |
| Hydrocortisone Displays Potential in Septic Shock Treatment |
| Reduced Levels of Vitamin C Characterize Sepsis Patients |
| Treatment with Hydrocortisone and Vitamin C Demonstrates Positive Impact on Mortality Rate |
| Intravenous Vitamins + Hydrocortisone Therapy Causes Waves in the Market |
| Researchers Develop ss-Sepsis-3 Protocol for Evaluation of Sepsis in Animal Models |
| World Sepsis Day Aims to Result in Improvement in Sepsis Management |
| NSAIDs Demonstrate Potential to Treat Sepsis |
| 4. GLOBAL MARKET PERSPECTIVE |
| Sepsis Therapeutics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025 |
| Sepsis Therapeutics Market Share Shift across Key Geographies Worldwide: 2019 VS 2025 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| United States |
| Market Facts & Figures |
| United States Sepsis Therapeutics Market Estimates and Projections in US$ Million: 2018 to 2025 |
| Canada |
| Canadian Sepsis Therapeutics Market Estimates and Forecasts in US$ Million: 2018 to 2025 |
| Japan |
| Japanese Market for Sepsis Therapeutics: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025 |
| China |
| Chinese Sepsis Therapeutics Market Growth Prospects in US$ Million for the Period 2018-2025 |
| Europe |
| Market Facts & Figures |
| European Sepsis Therapeutics Market Demand Scenario in US$ Million by Region/Country: 2018-2025 |
| European Sepsis Therapeutics Market Share Shift by Region/Country: 2019 VS 2025 |
| France |
| Sepsis Therapeutics Market in France: Estimates and Projections in US$ Million for the Period 2018-2025 |
| Germany |
| Sepsis Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Million for the Period 2018-2025 |
| Italy |
| Italian Sepsis Therapeutics Market Growth Prospects in US$ Million for the Period 2018-2025 |
| United Kingdom |
| United Kingdom Market for Sepsis Therapeutics: Annual Sales Estimates and Projections in US$ Million for the Period 2018-2025 |
| Rest of Europe |
| Rest of Europe Sepsis Therapeutics Market Estimates and Forecasts in US$ Million: 2018-2025 |
| Asia-Pacific |
| Sepsis Therapeutics Market in Asia-Pacific: Estimates and Projections in US$ Million for the Period 2018-2025 |
| Rest of World |
| Rest of World Sepsis Therapeutics Market Estimates and Forecasts in US$ Million: 2018 to 2025 |
| IV. COMPETITION |
| Total Companies Profiled : 29 Click here to request a full table of contents and more details on this project. |
INSIDER ACCESS TO
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com